Skip to content

Search for:

About us
SUPPORT FOR LIFE & PRODUCTS
- PRODUCTS
- REPORTING AN ADVERSE EVENT
PIPELINE
- TECHNOLOGY PARTNERSHIPS
- COMMERCIAL PARTNERSHIPS
PATIENTS & ADVOCACY
NEWS
CAREERS

Home/Cycle Pharmaceuticals Receives FDA Approval of Nityr™ (nitisinone) Tablets for Treatment of HT-1/nityr-logo-small

Previous

nityr-logo-small

nityr-logo-small

By Kierah Bircham|2017-08-01T10:36:38+01:00August 1st, 2017|

SHARE THIS ARTICLE :

Facebook Twitter LinkedIn

About the Author: Kierah Bircham

Legal Policies
REPORTING AN ADVERSE EVENT
Contact

CYCLE Pharmaceuticals Limited is registered in England and Wales. Registration number 07933058.

GL-0043 (Date of Preparation: September 2020)

UK: +44 1223 354118
US: +1 800 903 1793
info@cyclepharma.com